On the Structure of Solid Lipid Nanoparticles.

Area of Science:

• Materials Science
• Nanotechnology
• Biophysics

Background:

• Solid lipid nanoparticles (SLNs) are promising drug delivery vehicles due to their tunable lipid and surfactant components.
• Polymorphic transitions in the lipid core of SLNs can cause premature drug release, limiting their therapeutic potential.
• Existing research primarily focuses on experimental physicochemical properties, lacking molecular-scale insights into SLN formation and stability.

Purpose of the Study:

• To investigate the molecular-scale mechanisms driving the formation and polymorphic transitions of solid lipid nanoparticles.
• To elucidate how surfactants stabilize the crystalline lipid core of SLNs at an atomistic level.
• To understand the relationship between lipid morphology and drug encapsulation/release dynamics.

Main Methods:

• Utilized a combination of small-angle neutron scattering (SANS) and all-atom molecular dynamics (MD) simulations.
• Analyzed the internal structure of SLNs composed of tripalmitin and the nonionic surfactant Brij O10.
• Compared simulated SLN structures with liquid and solid tripalmitin aggregates.

Main Results:

• Uncovered the specific molecular-scale mechanisms by which surfactants stabilize the crystalline lipid core of SLNs.
• Provided a detailed atomistic description of the internal structure of tripalmitin-based SLNs.
• Demonstrated variations in lipid morphology between SLNs, liquid aggregates, and solid aggregates, offering insights into drug loading and release.

Conclusions:

• The study provides unprecedented molecular-level understanding of solid lipid nanoparticle stabilization and polymorphic behavior.
• Findings offer critical insights into controlling drug encapsulation and release by tailoring SLN lipid and surfactant composition.
• This research paves the way for designing more stable and effective SLN-based drug delivery systems.